Monogram OrthopaedicsNASDAQ: MGRM

Management to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will host an investor and analyst day on Thursday, June 20th, 2024, from 9:00 a.m. CDT to 1:00 p.m.

Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript

Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeons AUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, hosted a recorded discussion of features of Monogram's mBôs and mVision technologies with a surgeon panel. Monogram's mVision technology is a novel approach to registration and tracking that the company is now working on for integration into the mBôs surgical robotic system in the future.

AUSTIN, TX / ACCESSWIRE / January 24, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, announced today that management will present at the Canaccord Genuity 2024 Musculoskeletal Conference taking place February 12, 2024, in San Francisco. Ben Sexson, Chief Executive Officer, is scheduled to host a presentation during the conference and will also participate in one-on-one meetings with Chief Financial Officer Noel Knape during the conference.

Monogram Orthopaedics, Inc. went public in May 2023 and raised $17.2 million for its autonomous robotic surgical system for knee replacement surgery. The company is still in the development stage and will require significant additional capital to fund its plans. The stock is an ultra-high-risk investment, and my outlook is to Sell.

Monogram Orthopaedics (NASDAQ: MGRM ) stock is heading higher on Friday after the company's shares made their public debut on Thursday! The Monogram Orthopaedics IPO saw the company selling 2.4 million shares of MGRM stock at a price of $7.25 each.